Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Moodys
Johnson and Johnson
McKinsey
AstraZeneca

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Claims for Patent: 5,728,925

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,728,925
Title: Chimaeric gene coding for a transit peptide and a heterologous polypeptide
Abstract:Chimaeric DNA sequence which encodes: 1) a transit peptide of a cytoplasmic precursor of a chloroplast protein or polypeptide of a plant and 2) a protein or polypeptide that is heterologous to the transit peptide. The chimaeric DNA sequence can be used as a vector for transforming a plant cell so that a chimaeric precursor of the heterologous protein or polypeptide is produced in the cytoplasm of the cell and the chimaeric precursor then transports the heterologous protein or polypeptide in vivo into a chloroplast of the cell.
Inventor(s): Herrera-Estrella; Luis (Gent, BE), Van Den Broeck; Guido (Gent, BE), Van Montagu; Marc (Brussel, BE), Schreier; Peter (Cologne, DE), Schell; Jeff (Cologne, DE), Bohnert; Hans J. (Tucson, AZ), Cashmore; Anthony R. (Woodside, NY), Timko; Michael P. (New York, NY), Kausch; Albert P. (Durham, NH)
Assignee: Plant Genetic Systems, N.V. (Brussels, BE) Bayer A.G. (Leverkusen, DE)
Application Number:08/430,257
Patent Claims:1. A plant containing in its nuclear genome a chimaeric DNA sequence, comprising:

a) a nucleic acid sequence coding for a chimaeric protein or polypeptide comprising in sequence:

1) a transit peptide of a cytoplasmic precursor of a chloroplast protein or chloroplast polypeptide of a plant species, and

2) a protein or polypeptide of interest which is different from a mature chloroplast protein or chloroplast polypeptide derived from a natural cytoplasmic precursor thereof, and,

b) a promoter upstream of said nucleic acid sequence recognized by polymerases endogenous to said plant,

wherein the chimaeric DNA sequence can be expressed in cells of said plant under the control of said promoter, and said protein or polypeptide of interest is translocated into the chloroplasts of said cells of said plant.

2. The plant of claim 1, in which said protein or polypeptide of interest is of bacterial origin.

3. The plant of claim 1 in which said protein or polypeptide of interest is of plant origin.

4. The plant of claim 1 in which said protein or polypeptide of interest confers resistance to an herbicide.

5. The plant of claim 1 in which the first amino acid of said protein or polypeptide of interest is a methionine.

6. The plant of claim 1 in which no more than the first seven amino acids of said protein or polypeptide of interest are encoded by a synthetic nucleotide linker.

7. The plant of claim 1 in which the transit peptide is from a cytoplasmic precursor of a chloroplast protein selected from the group consisting of the small subunit of ribulose-1,5-bisphosphate carboxylase, and chlorophyll a/b binding protein.

8. The plant of claim 7 in which the transit peptide is from a cytoplasmic precursor of the small subunit of ribulose-1,5-bisphosphate carboxylase of a plant selected from the group consisting of soybean, pea, duckweed, and wheat.

9. The plant of claim 7 in which the transmit peptide has the sequence selected from the group consisting of: ##STR4##

10. The plant of claim 1 in which said promoter is normally associated with the DNA encoding said transit peptide.

11. The plant of claim 10 in which said promoter is a promoter of a gene selected from the group consisting of, the plastocyanin gene, the ferredoxin-NADP+ oxydoreductase gene, the ribulose-1,5-bisphosphate carboxylase gene, and the chlorophyll a/b binding protein gene.

12. The plant of claim 1 in which said promoter is foreign to the DNA encoding said transit peptide.

13. The plant of claim 12 in which said promoter is a promoter of the nopalin synthase gene.

14. A plant containing in its nuclear genome a chimaeric DNA sequence comprising:

a) a nucleic acid sequence coding for a chimaeric protein or polypeptide comprising in sequence:

1) a transit peptide of a cytoplasmic precursor of a chloroplast protein or chloroplast polypeptide of a plant species, and

2) a hybrid protein comprising in sequence:

2.1) a linker, and

2.2) a protein or polypeptide of interest which is different from said chloroplast protein or chloroplast polypeptide

wherein said linker does not significantly alter the biological property of said protein or polypeptide of interest in said hybrid protein, and

b) a promoter upstream of said nucleic acid sequence recognized by polymerases endogenous to a plant,

wherein the chimaeric DNA sequence is expressed in cells of said plant under the control of said promoter, and said hybrid protein is translocated into the chloroplasts of said cells of the plant.

15. The plant of claim 14, wherein said linker is a N-terminal part of a mature chloroplast protein or chloroplast polypeptide derived from a natural cytoplasmic precursor thereof.

16. The plant of claim 15 in which said protein or polypeptide of interest is of bacterial origin.

17. The plant of claim 15 in which said protein or polypeptide of interest is of plant origin.

18. The plant of claim 15 in which said protein or polypeptide of interest confers resistance to an herbicide.

19. The plant of claim 15, in which said N-terminal part is encoded by a DNA sequence that comprises an intron.

20. The plant of claim 15 in which the transit peptide is from a cytoplasmic precursor of a chloroplast protein selected from the group consistinf of: the small subunit of ribulose-1,5-bisphosphate carboxylase, and chlorophyll a/b binding protein.

21. The plant of claim 15 in which the transit peptide is from a cytoplasmic precursor of the small subunit of ribulose-1,5-bisphosphate carboxylase of a plant selected from the group consisting of: soybean, pea, duckweed, and wheat.

22. The plant of claim 21 in which the transit peptide has the sequence selected from the group consisting of: ##STR5##

23. The plant of claim 15 in which said promoter is normally associated with the DNA encoding said transit peptide.

24. The plant of claim 23 in which said promoter is a promoter of a gene selected from the group consisting of: the plastocyanin gene, the ferredoxin-NADP+oxydoreductase gene, the ribulose-1,5-bisphosphate carboxylase gene, and the chlorophyll a/b binding protein gene.

25. The plant of claim 15 in which said promoter is foreign to the DNA encoding said transit peptide.

26. The plant of claim 25 in which said promoter is a promoter of the nopaline synthase gene.

27. A plant containing in its nuclear genome a chimaeric DNA sequence comprising:

a) a nucleic acid sequence coding for a chimaeric protein or polypeptide comprising in sequence:

1) a transit peptide of a cytoplasmic precursor of a chloroplast protein or chloroplast polypeptide of a plant species, and,

2) a fusion protein comprising in sequence,

2.1) a N-terminal part consistinf of no more than the first 22 N-terminal amino acids of a mature chloroplast protein or chloroplast polypeptide derived from a natural cytoplasmic precursor thereof, and

2.2) a protein or polypeptide of interest which is different from said chloroplast protein or polypeptide and,

b) a promoter upstream of said nucleic acid sequence recognized by polymerases encodenous to said plant,

wherein the chimaeric DNA sequence is expressed in cells of said plant under the control of said promoter, and said fusion protein is translocated into the chloroplasts of said cells of said plant.

28. The plant of claim 27 in which said protein or polypeptide of interest is of bacterial origin.

29. The plant of claim 27 in which said protein or polypeptide of interest is of plant origin.

30. The plant of claim 27 in which said protein or polypeptide of interest confers resistance to an herbicide.

31. The plant of claim 27 in which said N-terminal part is encoded by a DNA sequence that comprises an intron.

32. The plant of claim 27 in which said N-terminal part is from the small subunit of the ribulose-1,5-bisphosphate carboxylase of Pisum sativum.

33. The plant of claim 27 in which said N-terminal part consists of no more than the first five N-terminal amino acids of said chloroplast protein or polypeptide.

34. The plant of claim 33 in which said N-terminal part has the sequence M-Q-V-W-P.

35. The plant of claim 27 in which the transit peptide is from a cytoplasmic precursor of a chloroplast protein selected from the group consisting of: the small subunit of ribulose-1,5-bisphosphate carboxylase, and chlorophyll a/b binding proteins.

36. The plant of claim 35 in which the transit peptide is from a cytoplasmic precursor of the small subunit of ribulose-1,5-bisphosphate carboxylase of a plant selected from the group consisting of soybean, pea, duckweed, and wheat.

37. The plant of claim 36 in which the transit peptide has the sequence selected from the group consisting of: ##STR6##

38. The plant of claim 27 in which said promoter is normally associated with the DNA encoding said transit peptide.

39. The plant of claim 38 in which said promoter is a promoter of a gene selected from the group consisting of: the plastocyanin gene, the ferredoxin-NADP+ oxydoreductase gene, the ribulose-1,5-bisphosphate carboxylase gene, and the chlorophyll a/b binding protein gene.

40. The plant of claim 27 in which said promoter is foreign to the DNA encoding said transit peptide.

41. The plant of claim 40 in which said promoter is a promoter of the nopalin synthase gene.

42. A seed of the plant of any one of claims 1 to 4, 7, 14, 15 and 27, comprising said chimaeric DNA sequence.

43. A cell of the plant of any one of claims 1 to 4, 7, 14, 15 and 27, comprising said chimaeric DNA sequence.

Summary for Patent:   Start Trial

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8432757Dec 28, 1984
United Kingdom8500336Jan 7, 1985

Details for Patent 5,728,925

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Plant Genetic Systems, N.V. (Brussels, BE) Bayer A.G. (Leverkusen, DE) 2015-03-17 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Plant Genetic Systems, N.V. (Brussels, BE) Bayer A.G. (Leverkusen, DE) 2015-03-17 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Plant Genetic Systems, N.V. (Brussels, BE) Bayer A.G. (Leverkusen, DE) 2015-03-17 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Baxter
Medtronic
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.